跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Diazo-oxo-L-norleucine
首页
药物
Diazo-oxo-L-norleucine
Diazo-oxo-L-norleucine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PRODRUGS OF GLUTAMINE ANALOGS
EP 3328827 B1
申请人: UNIV JOHNS HOPKINS
优先权: 2015
CN
EP
US
WO
12 件公开
PHARMACEUTICAL COMPOSITION, COMPRISING 6-DIAZO-5-OXO-L-NORLEUCINE, FOR TREATMENT OF INFLAMMATORY SKIN DISEASE
EP 3964215 A4
申请人: NATUREBLUE CO LTD
优先权: 2019
CN
EP
2 件公开
Medicament for the treatment of diseases caused by parasitic protozoa
US 7157449 B2
申请人: HOFER ANDERS
优先权: 2000
US
2 件公开
Glutadon
US 8465736 B2
申请人: BAUSCH MICHAEL
优先权: 2006
US
2 件公开
Glutamine antagonists for the treatment of cognitive deficits and psychiatric disorders
US 11110104 B2
申请人: UNIV JOHNS HOPKINS
优先权: 2018
US
Application of 6-diazo-5-oxo-L-norleucine in preparing medicine for preventing or curing hepatic carcinoma
CN 109045046 A
申请人: UNIV CHONGQING MEDICAL
优先权: 2018
CN
Methods for cancer and immunotherapy using prodrugs of glutamine analogs
US 11759444 B2
申请人: UNIV JOHNS HOPKINS
优先权: 2020
US
PRODRUGS OF 6-DIAZO-5-OXO-L-NORLEUCINE
US 2024246902 A1
申请人: UNIV JOHNS HOPKINS
优先权: 2022
US
药物
反馈